Featuring debriefs from the June 2020 Open Pharma roundtable meeting and the virtual 16th Annual Meeting of ISMPP, questions and answers on patient authorship, a joint letter urging publishers to reduce fee agreements with UK universities, a landmark deal from the University of California and the results of the COAR open access repository platform survey. … Continue reading Weekly digest: what’s happening in open science?
Featuring the questionable transparency of some COVID-19 data, retraction notices and clinical trial results, what COVID-19 has taught us about open access, a centralized archive of COVID-19 preprints, and how the pandemic may affect the public’s trust in science. Data transparency amid COVID-19 journal retractions via the BMJ The lessons learned from the British Medical … Continue reading Weekly digest: what’s happening in open science?
Featuring changes in publishing practices, a preprint on missing safety data, a copyright infringement lawsuit, promoting Principle 5 of Plan S and price transparency, PubMed’s new preprint platform, and how to define and identify predatory journals. Recipes for perpetuity via The Scholarly Kitchen This month’s installation of The Scholarly Kitchen’s Ask the Chefs column asks: … Continue reading Weekly digest: what’s happening in open science?
Featuring new endorsements of the Open Pharma position statement on open access, preprints, preprints, preprints, and updates on open access agreements from the University of California and swissuniversities. New organizational endorsements and 150 individual endorsements via Open Pharma Open Pharma is pleased to announce that we have now gained 150 individual endorsements on our position … Continue reading Weekly digest: what’s happening in open science?
Featuring an abstract from ISMPP’s 16th Annual Meeting, Springer Nature’s commitment to DORA, a reflection on how COVID-19 is impacting clinical research, interpretations of the meaning of open science, preprint policy updates from PLOS, a public appeal to the EMA and what’s standing in the way of open access. Coco et al. 2020: surveying open … Continue reading Weekly digest: what’s happening in open science?
For many stakeholders within the healthcare industry, the world of open research is an exciting yet occasionally confusing one. At the start of this year, key industry players from across the pharma industry met in Oxford for a roundtable discussion hosted by Wiley on ‘How the pharma–publisher relationship should evolve in the new world of … Continue reading Guest post: The open road
Featuring eLife’s new peer review service, quality control measures for preprint servers, STM’s Innovation Day keynote on ethics and data science, a task force to tackle image duplication, a call for improved open access infrastructure, ASBMB’s commitment to open access and a response from the British Library. A peer review service for preprints via eLife … Continue reading Weekly digest: what’s happening in open science?
Featuring top tips for maintaining accuracy and integrity in scientific reporting, the need to share algorithmic inputs of scientific models, efforts to streamline and improve time-to-publication metrics and peer review processes, Evidence Aid’s work on coronavirus research summaries and CRUK’s commitment to Plan S. Maintaining journalistic integrity in the era of preprint servers via Columbia … Continue reading Weekly digest: what’s happening in open science?
Featuring new endorsements of the Open Pharma position statement on open access, the ISMPP U webinar on COVID-19 and publication planning, an effort to make ClinicalTrials.gov more user-friendly, the importance of lay summaries, a coalition of publishers, the COVID-19 Antiviral Candidate Compounds Dataset, an investigation into the diversity of preprint servers and an analysis into … Continue reading Weekly digest: what’s happening in open science?
Featuring the driving forces of open science, the European COVID-19 Data Portal, the launch of IndiaRxiv, a survey investigating opinions on co-reviewing, a study on open science principles, how COVID-19 is reshaping science and a breakdown of the Creative Commons licences. A tale of two ‘buts’ via WONKHE Elizabeth Gadd, Research Policy Manager at Loughborough … Continue reading Weekly digest: what’s happening in open science?